Evidence Based Medicine presented by InpharmD™-logo

Evidence Based Medicine presented by InpharmD™

Health & Wellness Podcasts

We take the most popularly asked clinical questions monthly and create a class around the corresponding evidence. Our EBM podcast will offer a glimpse into the evidence covered, and listeners can follow up with our CE if interested in more information.

Play Button

Location:

United States

Description:

We take the most popularly asked clinical questions monthly and create a class around the corresponding evidence. Our EBM podcast will offer a glimpse into the evidence covered, and listeners can follow up with our CE if interested in more information.

Language:

English

Episodes

Safety and Efficacy of Rezafungin

7/20/2023
Join us as we discuss the data surrounding newly approved antifungal agent, rezafungin. Interested in learning more? Join our CE on rezafungin on July 27th at 12:00 PM EST - open to all pharmacists!

Duration:00:09:41

Perioperative Duloxetine During Orthopedic Surgery for Pain Reduction

6/13/2023
Join InpharmD as we discuss the data on perioperative duloxetine (Cymbalta) during orthopedic surgery for pain reduction. Interested in the full data response? Read here!

Duration:00:08:26

Lecanemab in the treatment of Alzheimer’s Dementia

4/17/2023
Every month, InpharmD creates a continuing-education (CE) class on the most commonly asked drug information question and the related evidence. Our podcast offers a sneak peak into our CE as we briefly discuss the topic. Episode-2 looks at the safety and efficacy of lecanemab in the treatment of Alzheimer’s dementia.

Duration:00:09:28

Tirzepatide for Weight Loss in Diabetic Patients

3/6/2023
Join us as we discuss the evidence surrounding tirzepatide for weight loss in diabetic patient populations.

Duration:00:08:53

Yet Another Drug Shortage? Alternatives to Oxytocin

10/14/2022
Many hospitals have been dealing with the recent oxytocin shortage. With this episode, we discuss possible alternatives and adjuncts to oxytocin, based on the evidence available.

Duration:00:04:58

Can Evusheld Increase Cardiovascular Events?

9/26/2022
Tune in as we discuss the PROVENT trial and the on-going TACKLE trial to determine whether or not Evusheld can increase cardiovascular events.

Duration:00:04:48

Could Intermittent Fasting be the Next Big Weight Loss Tool?

6/21/2022
A randomized clinical trial conducted to assess time-restricted eating with calorie restriction as compared with daily calorie restriction alone for the effects on weight loss and metabolic risk factors in obese patients.

Duration:00:04:30

A 4th Dose of the COVID-19 Vaccine

4/29/2022
A regression analysis conducted in Israel showed that a fourth dose appeared to increase the protection against severe illness relative to three doses that were administered more than 4 months earlier. Further studies are needed before applying this to a larger population.

Duration:00:05:47

A Possible Alternative for Recurrent Urinary Tract Infections

4/21/2022
A multicenter, randomized, open label, non-inferiority trial conducted to test and compare the efficacy of methenamine hippurate for prevention of recurrent urinary tract infections (UTI) with the current standard prophylaxis of daily low dose antibiotics.

Duration:00:05:43

Estimation of Breast Cancer Overdiagnosis

3/25/2022
A cohort study conducted to estimate the rate of breast cancer overdiagnosis in contemporary mammography practice accounting for the detection of nonprogressive cancer.

Duration:00:04:56

Can Ketamine Treat Acute, Severe Suicidal Ideation?

3/14/2022
A prospective, double blind, superiority, randomized placebo-controlled trial conducted to confirm the rapid onset anti-suicidal benefits of ketamine in the short term and at six weeks.

Duration:00:04:49

Could SER-109 be an Answer for Recurrent C.Difficile Infection?

2/22/2022
A phase 3, double-blind, randomized, placebo-controlled trial conducted to show superiority of SER-109 in reducing the risk of C. difficile infection recurrence up to 8 weeks after treatment.

Duration:00:05:11

To Boost or not to Boost - That is the Question

2/11/2022
A retrospective study conducted to assess for any decrease in mortality associated with the use of the BNT162b2 (BioNTech, Pfizer vaccine) booster.

Duration:00:05:37

Old Dogs Can Learn New Tricks: Is Outpatient Remdesivir a Game Changer against Omicron?

1/20/2022
A double-blind, randomized, placebo-controlled trial conducted to evaluate the efficacy and safety of a 3-day course of remdesivir in high-risk, non-hospitalized patients with COVID-19.

Duration:00:06:25

Can Financial Incentives Help Pregnant Patients Quit Smoking?

1/6/2022
A single-blind, multicenter, randomized, controlled trial conducted to evaluate the efficacy of financial incentives dependent on continuous smoking abstinence on smoking cessation and birth outcomes among pregnant smokers.

Duration:00:05:08

Milvexian for the Prevention of Venous Thromboembolism

12/22/2021
An open-label, randomized, parallel-group, adaptive design with blinded outcome adjudication trial conducted to compare the efficacy and safety of milvexian and enoxaparin in patients undergoing elective knee arthroplasty.

Duration:00:08:16

Merck's New COVID-19 Pill - Molnupiravir

12/1/2021
The first in-human, phase 1, randomized, double-blind, placebo-controlled study conducted to determine the safety, tolerability, and pharmacokinetics of single and multiple ascending oral doses of molnupiravir in healthy subjects.

Duration:00:05:21

Can chlorthalidone therapy improve blood-pressure control in patients with advanced CKD?

11/25/2021
A double-blind, randomized, placebo-controlled trial conducted to assess the role of chlorthalidone for hypertension in advanced chronic kidney disease.

Duration:00:07:02

Does the Addition of Vasopressin and Methylprednisolone Improve Outcomes in Patients with In-Hospital Cardiac Arrest?

11/17/2021
An investigator-initiated, multi-center, randomized, double-blind, superiority, placebo-controlled conducted to determine whether the combination of vasopressin and methylprednisolone administered during in-hospital cardiac arrest improves return of spontaneous circulation.

Duration:00:06:11

Can fluvoxamine prevent COVID-19 related hospitalization?

11/10/2021
A randomized, adaptive, platform trial conducted to assess the efficacy of fluvoxamine versus placebo in preventing hospitalization (defined as either retention in a COVID-19 emergency setting or transfer to a tertiary hospital due to COVID-19).

Duration:00:05:54

See More